After over 40 years collectively at the helm of investment banking & venture capital in Singapore, HK and Taipei, Daniel Harel and Yishai Klein realised Asia was not tapping into the upside of Israeli tech.
Determined to unlock the potential of the two markets, BlueRed Partners was formed to link Family Offices in Asia with growth-stage technology firms in Israel.
“ We take great pride in our Limited Partners, who act as investors and market-openers
InZiv designs and manufactures the next generation of inspection tools for microLED and QLED displays. Based on highly specialized nano-scale optics and near-field microscopy, InZiv tools are uniquely suited to address the quality assurance needs for today’s display panels. Earlier detection of defects in pixels yields substantial financial savings for display panel manufacturers.
Investment year: 2022Sector: NanotechnologyGo to site
RenalSense is dedicated to real-time renal diagnostics. The company's first product, Clarity RMS, is a critical care digital monitoring system for early detection of changes in renal function and acute kidney injury (AKI) risk.
Investment year: 2021Sector: Digital Health/ Real-Time Renal DiagnosticsGo to site
Panorays is dedicated to eliminating third-party security risk so that companies worldwide can quickly and securely do business together. They automate, accelerate and scale customers’ vendor security evaluation and risk management process, resulting in efficient and effective risk remediation in alignment with customers’ security policies and risk appetite.
Investment year: 2021Sector: CyberSecurityGo to site
Optibus leverages a robust combination of artificial intelligence, advanced optimization algorithms, and distributed cloud computing to make public transportation smarter, better, and more efficient. Optibus' platform optimises bus scheduling to provide better services to passengers, encourage freedom of movement, and help develop sustainable cities.
Investment year: 2020Sector: AI / Public TransportationGo to site
Cynet is a pioneer and leader in advanced threat detection and response. It has developed the world’s first autonomous breach protection platform that consolidates and automates Monitoring & Control, Attack Prevention & Detection and Response Orchestration across the entire environment.
Investment year: 2020Sector: CyberSecurityGo to site
Gauzy is a world leading vendor of material science, focused on developing, manufacturing and marketing LCG® (Light Control Glass) technology. As the only company in the world working with two of the three active light control technologies, SPD and PDLC, Gauzy is a true pioneer in its field.
Investment year: 2019Sector: Nanotechnology / Material ScienceGo to site
By leveraging breakthroughs in secure multi-party computation (SMPC), Unbound protects secrets such as cryptographic keys by ensuring they never exist in complete form.
Investment year: 2019Exit: 2021, CoinbaseSector: Fintech / CyberSecurityGo to site
DouxMatok is a leader in Targeted Delivery of Flavor Ingredients, such as sugar and salt, enabling healthier consumption of foods without compromising taste. They enable a reduction of 40% or more in sugar and salt, while fully retaining the same sugar or salt “experience.”
Investment year: 2019Sector: FoodtechGo to site
EarlySense has introduced an innovative continuous patient monitoring solution designed to enhance patient safety and reduce risk for general care patients. Founded in 2004, EarlySense is a dynamic, rapidly growing company focused on next generation patient monitoring systems for hospitals, healthcare systems, integrated delivery networks and rehabilitation centers.
Investment year: 2019Sector: Digital HealthcareGo to site
InZiv, a technology provider of high-resolution inspection and repair of microLED, QLED, and OLED displays, announced that it has raised US$10 million in a Series A1 round led by BlueRed Partners, a Singapore based venture capital fund..
SINGAPORE-BASED venture capital firm BlueRed Partners has led a US$10 million Series A fundraising round for Israeli tech startup InZiv, it announced on Tuesday (Apr 26).
Pursuant to that point, Coinbase, one of the leading cryptocurrency exchanges, has acquired Israels Unbound Security to cater to this growing need for privacy in the blockchain ecosystem.
The BBC had a chat with Amos Haggiag, who is the CEO and co-founder of Optibus.
Look closely at the ingredients of Super Super Bars, and youll see that the list includes Incredo sugar, incorporating sugar-reduction technology from Israel.
The companys flagship product is a critical care monitoring system that automatically monitors urine flow to enable early detection of changes in renal function and Acute Kidney Injury risk.
New products being offered by the Israeli company will include camera based image analysis and monitoring systems, and smart mirrors with light control elements.
A new year leads to new challenges, but organizations should refer to history to help mitigate risk. Panorays Co-Founder and CTO Demi Ben Ari delves deeper.
DouxMatok, an Israeli firm that is shaking up sugar reduction with patented technology that heightens the perception of sweetness, is teaming with Blommer Chocolate to produce a ‘game changing’ portfolio of chocolate products with significantly less sugar, but which taste and function the same as their conventional counterparts.
The company’s flagship product is a critical care monitoring system that automatically monitors urine flow to enable early detection of changes in renal function and Acute Kidney Injury risk.
Scientists continue to innovate: Incredo is an extra-sweet sucrose-silica substitute, which allows 30 to 50 per cent less sugar to be used without losing sweetness. And Michelin-starred Thomas Keller of The French Laundry recently showcased Supplant – a sweetener derived from plant fibres – in chocolate that he stated was as delicious as any made in his restaurant.
RenalSense™, a leader in real-time renal diagnostics, today announced it has secured $14M. The Series A round was led by BlueRed Partners Fund (Singapore) and includes several large healthcare-focused family offices as well as existing shareholders.
DouxMatok, the Israeli firm behind patented technology that makes regular sugar taste sweeter, has launched limited-edition chocolate spreads in the US with half the sugar of leading brands to give consumers the chance to taste products made with its ‘Incredo’ enhanced sugar for the first time
Scientists appear to have cracked the great public health challenge of their generation: an effective vaccine for Covid-19. But what if a cure were developed for something just as deadly as the virus: sugar?
What if your baked goods, chocolates and candy could taste just as sweet while containing a lot less sugar? Incredo Sugar is a newly engineered form of the sweetener that allows bakers and food companies to reduce sugar content by 30-50% while retaining the same level of sweetness. That means it could help to reduce sugar consumption (and the host of health problems it causes.
Forget artificial sweeteners. Researchers are now developing new forms of real sugar, to deliver sweetness with fewer calories. But tricking our biology is no easy feat. Nicola Twilley from the New Yorker sits with the founding C.E.O. of DouxMatok, Eran Baniel, to get up to speed with the current state of the art.
DouxMatok has struck a deal with a North American sugar refiner to manufacture commercial quantities of its ‘enhanced’ sugar, likely to hit the US market in Q1, 2021.
Venafi and Unbound Tech announce a partnership to enable enterprises managing machine identities and communication a seamless deployment and user experience, without compromising on security.
Singapore-based BlueRed Partners has led a US$18-million, extended Series B fundraising in US-based cyber security startup Cynet, the venture firm announced in a statement on Tuesday..
Guy Meger, the chief technology officer of nonintrusive patient monitoring company EarlySense, believes the pandemic helped eliminate innovation-blocking hurdles
Israeli smart glass, material science and nanotechnology company Gauzy has raised a Series C financing round from Hyundai Motor Company, Blue Red partners VC, and Avery Dennison...
BlueRed Partners has led a US$22 million Series B funding round in Israel-based sugar reduction solution startup DouxMatok.
BlueRed Partners has raised US$75 million for its inaugural US$100 million fund, which aims to connect the bustling deep-tech scene in Israel to South-east Asia's prominent business families.
The investment comes after EarlySense integrated its continuous contact-free heart rate and respiratory rate sensing and analytics technology into Hill-Rom's....